These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37339)

  • 1. Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols.
    Rzeszotarski WJ; Gibson RE; Eckelman WC; Reba RC
    J Med Chem; 1979 Jun; 22(6):735-7. PubMed ID: 37339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioselectivity as a function of molecular structure in beta-adrenoceptor blocking agents of the 1-(para-substituted aryloxy)-3-(isopropylamino)propan-2-ol type.
    Erez M; Shtacher G; Weinstock M
    J Med Chem; 1978 Sep; 21(9):982-4. PubMed ID: 31488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioselectivity of beta-adrenoceptor blocking agents. 2. Role of the amino group substituent.
    Rzeszotarski WJ; Gibson RE; Simms DA; Jagoda EM; Vaughan JN; Eckelman WC
    J Med Chem; 1983 May; 26(5):644-8. PubMed ID: 6132998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Adrenergic blocking agents. 18. 1-(Aryloxy)-3-(arylthioalkylamino)propan-2-ols and 1-substituted alkylthioamino-3-(aryloxy)propan-2-ols.
    Tucker H; Coope JF
    J Med Chem; 1978 Aug; 21(8):769-73. PubMed ID: 29123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines.
    Lemke TL; Cramer MB; Adamski SW; Pedone CA; Brooker G
    J Med Chem; 1981 Oct; 24(10):1211-4. PubMed ID: 6120233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino)propan-2-ols.
    Tucker H
    J Med Chem; 1980 Oct; 23(10):1122-6. PubMed ID: 6106716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
    Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
    J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
    [No Abstract]   [Full Text] [Related]  

  • 8. beta-adrenergic blocking agents. 24. Heterocyclic substituted 1-(aryloxy)-3-[[(amido)alkyl]amino]propan-2-ols.
    Large MS; Smith LH
    J Med Chem; 1982 Dec; 25(12):1417-22. PubMed ID: 6130155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
    Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
    J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo receptor binding of iodinated beta-adrenoceptor blockers.
    Eckelman WC; Gibson RE; Vieras F; Rzeszotarski WJ; Francis B; Reba RC
    J Nucl Med; 1980 May; 21(5):436-42. PubMed ID: 6103024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-ols.
    Large MS; Smith LH
    J Med Chem; 1983 Mar; 26(3):352-7. PubMed ID: 6131134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodinated derivatives of beta adrenoceptor blockers for myocardial imaging.
    Jiang VW; Gibson RE; Rzeszotarski WJ; Eckelman WC; Reba RC
    J Nucl Med; 1978 Aug; 19(8):918-24. PubMed ID: 28388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence of two types of beta adrenoceptor binding site in lung tissue.
    Barnett DB; Rugg EL; Nahorski SR
    Nature; 1978 May; 273(5658):166-8. PubMed ID: 25391
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis and beta-adrenergic blocking activity of 1-amino-3-(1,3-dioxalan-2-ylphenyloxy) propan-2-ols and 1-amino-3-(183-dioxan-2-ylphenyloxy)-propan-2-ols (author's transl)].
    Janiak PS; Moser U; Mutschler E
    Arch Pharm (Weinheim); 1978 Feb; 311(2):131-5. PubMed ID: 25640
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of beta adrenoceptor antagonist affinity and cardioselectivity by radioligand-receptor assay.
    Gibson RE; Rzeszotarski WJ; Komai T; Reba RC; Eckelman WC
    J Pharmacol Exp Ther; 1979 Apr; 209(1):153-61. PubMed ID: 34714
    [No Abstract]   [Full Text] [Related]  

  • 16. o-Chlorobenzenesulfonamidic derivatives of (aryloxy)propanolamines as beta-blocking/diuretic agents.
    Cecchetti V; Fravolini A; Schiaffella F; Tabarrini O; Bruni G; Segre G
    J Med Chem; 1993 Jan; 36(1):157-61. PubMed ID: 8093626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, binding affinity and selectivity of new beta 1- and beta 2-adrenoceptor blockers.
    Brizzi V; Francioli M; Brufani M; Filocamo L; Bruni G; Massarelli P
    Farmaco; 1999; 54(11-12):713-20. PubMed ID: 10668169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-short-acting beta-adrenergic receptor blocking agents. 3. Ethylenediamine derivatives of (aryloxy)propanolamines having esters on the aryl function.
    Erhardt PW; Woo CM; Matier WL; Gorczynski RJ; Anderson WG
    J Med Chem; 1983 Aug; 26(8):1109-12. PubMed ID: 6135805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization of a new highly cardioselective beta-adrenoceptor antagonist.
    Gobbi M; Mennini T; Ratti E
    J Pharm Pharmacol; 1988 Apr; 40(4):243-6. PubMed ID: 2900302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases.
    Manoury PM; Binet JL; Rousseau J; Lefèvre-Borg F; Cavero IG
    J Med Chem; 1987 Jun; 30(6):1003-11. PubMed ID: 2884312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.